Incidence and Risk Factors of Symptomatic Venous Thromboembolism Following Foot and Ankle Surgery

Abstract

Background:

The incidence rate of venous thrombotic events (VTEs) following foot and ankle surgery is low. Currently, there is no consensus regarding postoperative prophylaxis or evidence to support risk stratification.

Methods:

A 2-part study assessing the incidence and factors for the development of VTE was conducted: (1) a retrospective observational cohort study of 22 486 adults to calculate the overall incidence following foot and/or ankle surgery from January 2008 to May 2011 and (2) a retrospective matched case-control study to identify risk factors for development of VTE postsurgery. One control per VTE case matched on age and sex was randomly selected from the remaining patients.

Results:

The overall incidence of VTE was 0.9%. Predictive risk factors in bivariate analyses included obesity, history of VTE, history of trauma, use of hormonal replacement or oral contraception therapy, anatomic location of surgery, procedure duration 60 minutes or more, general anesthesia, postoperative nonweightbearing immobilization greater than 2 weeks, and use of anticoagulation. When significant variables from bivariate analyses were placed into the multivariable regression model, 4 remained statistically significant: adjusted odds ratio (aOR) for obesity, 6.1; history of VTE, 15.7; use of hormone replacement therapy, 8.9; and postoperative nonweightbearing immobilization greater than 2 weeks, 9.0. The risk of VTE increased significantly with 3 or more risk factors (P = .001).

Conclusion:

The overall low incidence of VTE following foot and ankle surgery does not support routine prophylaxis for all patients. Among patients with 3 or more risk factors, the use of chemoprophylaxis may be warranted.

Level of Evidence:

Level III, retrospective case series.

Keywords

blood clots deep vein thrombosis pulmonary embolus venous thromboprophylaxis

Get full access to this article

View all access options for this article.

References

Ahmad

Lynch

Maltenfort

Incidence and risk factors of venous thromboembolism after orthopaedic foot and ankle surgery. Foot Ankle Spec. 2017;10(5):449-454.

Calder

Freeman

Domeij-Arverud

van Dijk

Ackermann

PW.

Meta-analysis and suggested guidelines for prevention of venous thromboembolism (VTE) in foot and ankle surgery. Knee Surg Sports Traumatol Arthrosc. 2016;24(4):1409-1420.

Chao

Deep vein thrombosis in foot and ankle surgery. Orth Clin. 2016;47(2):471-475.

Felcher

Mularski

Mosen

Kimes

DeLoughery

Laxson

SE.

Incidence and risk factors for venous thromboembolic disease in podiatric surgery. Chest. 2009;135(4):917-922.

Griffiths

Matthews

Pearce

Calder

Incidence of venous thromboembolism in elective foot and ankle surgery with and without aspirin prophylaxis. J Bone Joint Surg Br. 2012;94B(2):210-214.

Hamilton

Hariharan

Robinson

Thromboprophylaxis in elective foot and ankle patients—current practice in the United Kingdom. Foot Ankle Surg. 2011;17(2):89-93.

Haque

Bishnoi

Khairandish

Menon

Thromboprophylaxis in ambulatory trauma patients with foot and ankle fractures: prospective study using a risk scoring system. Foot Ankle Spec. 2016;9(5):388-393.

Jameson

Augustine

James

et al . Venous thromboembolic events following foot and ankle surgery in the English National Health Service. J Bone Joint Surg Br. 2011;93B(4):490-497.

Kock

Schmit-Neuerburg

Hanke

Rudofsky

Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg. Lancet. 1995;346(8973):459-461.

10.

Lapidus

Ponzer

Elvin

et al . Prolonged thromboprophylaxis with dalteparin during immobilization after ankle fracture surgery: a randomized placebo-controlled, double-blind study. Acta Orthop. 2007;78(4):528-535.

11.

Lapidus

Rosfors

Ponzer

et al . Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture: a randomized, placebo-controlled study. J Orthop Trauma. 2007;21(1):52-57.

12.

Leonardi

McGory

CY.

The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. Arch Surg. 2006;141(8):790-799.

13.

Makhdom

Cota

Saran

Chaytor

Incidence of symptomatic deep venous thrombosis after Achilles tendon rupture. J Foot Ankle Surg. 2013;52(5):584-587.

14.

Mizel

Temple

Michelson

Alvarex

Clanton

Frey

Thromboembolism after foot and ankle surgery. Clin Orthop. 1998;348:180-185.

15.

Muntz

Scott

Lloyd

Egger

Major bleeding rates after prophylaxis against venous thromboembolism: systematic review, meta-analysis, and cost implications. Int J Technol Assess Health Care. 2004;20(4):405-414.

16.

Ouriel

Green

Greenberg

Clair

DG.

The anatomy of deep venous thrombosis of the lower extremity. J Vasc Surg. 2000;31(5):895-900.

17.

Parvizi

Huang

Restrepo

et al . Low-dose aspirin is effective chemoprophylaxis against clinically important venous thromboembolism following total joint arthroplasty: a preliminary analysis. J Bone Joint Surg. 2017;99(2):91-98.

18.

Patil

Gandhi

Curzon

Hui

Incidence of deep-vein thrombosis in patients with fractures of the ankle treated in a plaster cast. Bone Jt J. 2007;89(10):1340-1343.

19.

Pelet

Roger

M-E

Belzile

Bouchard

The incidence of thromboembolic events in surgically treated ankle fracture. J Bone Joint Surg. 2012;94A(6):502-506.

20.

Radl

Kastner

Aigner

Portugaller

Schreyer

Windhager

Venous thrombosis after hallux valgus surgery. J Bone Joint Surg. 2003;85A(7):1204-1208.

21.

Riou

Rothmann

Lecoules

et al . Incidence and risk factors for venous thromboembolism in patients with nonsurgical isolated lower limb injuries. Am J Emerg Med. 2007;25(5):502-508.

22.

Rosendaal

FR.

Venous thrombosis: a multicausal disease. Lancet. 1999;353(9159):1167-1173.

23.

Saragas

Ferrao

PNF

Saragas

Jacobson

BF.

The impact of risk assessment on the implementation of venous thromboembolism prophylaxis in foot and ankle surgery. Foot Ankle Surg. 2014;20(2):85-89.

24.

Selby

Geerts

Prevention of venous thromboembolism: consensus, controversies, and challenges. Am Soc Hematol Ed Prog. 2009;2009(1):286-292.

25.

Shah

Thevendran

Younger

Pinney

SJ.

Deep-vein thrombosis prophylaxis in foot and ankle surgery: what is the current state of practice?

Foot Ankle Spec. 2015;8(2):101-106.

26.

Shibuya

Frost

Campbell

Davis

Jupiter

DC.

Incidence of acute deep vein thrombosis and pulmonary embolism in foot and ankle trauma: analysis of the National Trauma Data Bank. J Foot Ankle Surg. 2012;51(1):63-68.

27.

Solis

Saxby

Incidence of DVT following surgery of the foot and ankle. Foot Ankle Int. 2002;23(5):411-414.

28.

Wolf

DiGiovanni

CW.

A survey of orthopedic surgeons regarding DVT prophylaxis in foot and ankle trauma surgery. Orthopedics. 2004;27(5):504-508.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.14 MB